A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs new agreement to use the Personalis NeXT Platform in clinical studies of mRNA-4157/V940, a personalized cancer vaccine jointly developed with Merck; platform will sequence patient genomic information to identify unique genetic mutations
Published: February 06, 2023 by ENP Newswire
Novartis reports patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Cosentyx; HS is a painful and recurrent inflammatory skin disease2
Published: February 06, 2023 by ENP Newswire
CARsgen Therapeutics partners with Roche to assess CARsgen's investigational drug AB011 combined with Roche’s atezolizumab, standard-of-care chemotherapy to treat gastric or gastroesophageal junction cancer; Roche to handle operations, clinical trial
Published: February 01, 2023 by MarketLine
Gerresheimer presents its new Clinical Trial Kit at Pharmapack in Paris; kit consists of sterile Gx RTF vials in nest and tub or tray with matching closures, is tailored for the development of new drugs, vaccines and biologics in early phases
Published: February 01, 2023 by Gerresheimer AG
Rise Therapeutics Announces FDA Clearance of its IND Application to Initiate a Phase 1 Study of an Oral Immunotherapy for the Treatment of Ulcerative Colitis
Published: January 31, 2023 by PR Newswire

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count